NEW YORK, May 29 - Venture-capital firm Sprout Group has hired former GlaxoSmithKline chief science and technology officer James Niedel, the company said yesterday.
Niedel will be venture partner for health-care technology investments.
Between 1995 and 2001, Niedel was a board member at Glaxo Wellcome, where he oversaw global R&D, information technology, and product strategy.
The Sprout Group is a venture capital affiliate of Credit Suisse First Boston.
Functional-genomics company Galapagos Genomics said on May 21 that it had hired Robin Brown as chief scientific officer.
Brown will direct the company's R&D, particularly in drug target discovery and validation.
He was previously chief scientific officer at the Belgian firm Devgen, and prior to that was at Glaxo Wellcome.
Galapagos is headquartered in Mechelen, Belgium. It is privately held.